Hormone Therapy

For Women
The menopausal transition, what changes before periods stop, and how evaluation works.
→ Read this partFor Men
Testosterone deficiency, what the testing actually shows, and when treatment is appropriate.
→ Read this partFor Women
Hormone Therapy for Women
What's changed
The medical climate around hormone therapy has changed.
For years, large studies raised concerns about hormone therapy, particularly around breast cancer, cardiovascular disease and blood clots. The message many women heard was simple: hormones were dangerous.
The result was a dramatic change in medical practice. Many women stopped hormone therapy, and many others never had the opportunity to consider it.
But the research continued.
As investigators looked more closely at the evidence, a more nuanced picture emerged. Age, timing, the type of hormone, route of administration, dose and a woman's individual health history all influence the balance of benefits and risks.
What once appeared settled was not.
Today, the question is no longer simply whether hormone therapy is "safe" or "unsafe." It is whether it is appropriate for you, at this point in your life, and which approach makes sense for your physiology and health.
What the evidence supports now
Timing matters.
For many healthy women who are younger than 60 or within approximately 10 years of menopause onset, hormone therapy may have a favorable benefit-risk profile when there are no contraindications.
Hormone therapy remains the most effective treatment for hot flashes and night sweats. It also helps prevent the accelerated bone loss that accompanies estrogen decline.
But menopause is not simply an estrogen story.
Estrogen, progesterone and testosterone change during the menopausal transition, and each has effects beyond reproduction. They interact with sleep, mood, cognition, sexual function, muscle, bone, metabolism and overall physical function.
Other systems matter too. Thyroid function, adrenal signaling, insulin and metabolic health can influence how a woman experiences this transition.
This is why two women with similar hormone levels can feel very different.
Hormone therapy can include hormones that are similar in chemical structure to those naturally produced by the body. The appropriate hormone, formulation, route and dose depend on the woman and her clinical circumstances.
Before anything has stopped
Hormonal change often begins years before periods become irregular — commonly in the forties, sometimes earlier.
This is the part most often missed. Cycles can still be regular. Standard labs can look normal. A woman can be told she is too young for this to be the explanation.
But hormones in this phase do not decline in a steady line. They fluctuate, sometimes dramatically, and the symptoms that follow can be more disruptive than anything that comes later. Sleep, mood and cognition are frequently affected first.
Because levels change day to day, a single hormone measurement drawn at one point in a cycle can be misleading. Evaluation in this phase depends more on the pattern of symptoms, their timing and the full clinical picture than on any one number.
Treatment here is also different. Fertility has not ended, cycles may still need to be accounted for, and the approach to progesterone and dosing differs from therapy begun after periods have stopped.
The symptoms nobody connects
Menopause does not always announce itself with a hot flash.
Sometimes it looks like waking at 3 a.m. and lying awake for hours.
A mood that feels unfamiliar. New anxiety. Losing a word you know perfectly well. Brain fog. A change in motivation. Joint aches. Changes in sexual desire or function. Fatigue. Waking unrefreshed. Changes in body composition or weight despite doing what you have always done.
These symptoms are often attributed to stress, depression, poor sleep, work, family demands—or simply getting older.
Sometimes those explanations are correct.
But changing hormones can be part of the picture.
The menopausal transition can affect multiple systems at once. Seeing the pattern can turn a collection of seemingly unrelated symptoms into something that can be evaluated.
Beyond hot flashes
Estrogen does much more than regulate body temperature.
Its effects extend across bone, cardiovascular health, the brain, metabolic function and the genitourinary system. The menopausal transition is also associated with changes in muscle and body composition.
This is where the conversation becomes larger than symptom control.
Hormone therapy is not a general-purpose longevity treatment, and it is not appropriate for every woman. But when appropriately prescribed, it may be one component of protecting bone, physical function and quality of life during the years beyond menopause.
The goal is not simply to make menopause disappear.
It is to understand what is changing in your body and decide what deserves attention.
Who benefits, who doesn't
Hormone therapy is not right for every woman.
The decision depends on your age, where you are in the menopausal transition, your symptoms, whether you have a uterus, your medical and family history, cardiovascular and clotting risks, breast and uterine considerations, and the type and route of therapy being considered.
For some women, hormone therapy can make a profound difference in sleep, vasomotor symptoms, mood, sexual function, physical comfort and quality of life.
For others, the risks may outweigh the potential benefits, or another approach may be more appropriate.
There is no universal prescription.
There is also no universal expiration date.
How evaluation works at Metaglow
We begin with the woman, not a single laboratory value.
We want to understand when your symptoms began, how they have changed, where you are in the menopausal transition, and what else may be influencing how you feel.
We look at your medical history, medications, nutrition, sleep, stress, metabolic health and other factors that can interact with hormonal function.
Hormone testing is an important part of evaluation. It can help us understand your hormonal environment and provide additional information when considered alongside your symptoms, history and clinical picture.
When hormone therapy is appropriate, we look at the hormones that may be relevant, the formulation, route and dose, and the role of progesterone when systemic estrogen is prescribed for a woman with a uterus.
Treatment is not static. Your response, symptoms, health and goals are followed over time.
The goal is not simply to replace what has been lost.
It is to understand what has changed—and help you feel and function more like yourself again.
Frequently Asked Questions
Do I have to have hot flashes to consider hormone therapy?
No. Hot flashes and night sweats are the most recognized symptoms of menopause, but they are far from the only ones. Sleep disruption, anxiety, mood changes, brain fog, joint symptoms, sexual changes and genitourinary symptoms may also be part of the menopausal transition.
Is hormone therapy safe?
The answer depends on the woman, the timing and the therapy being used. Age, time since menopause, formulation, route, dose and individual medical history all affect the balance of benefits and risks.
Is it too late for me to start?
Not necessarily. Starting hormone therapy later in menopause is a different clinical situation from starting during or near the menopausal transition. Your age, time since menopause and health history all matter.
Do I need hormone testing?
Yes. Hormone testing can provide important information about your hormonal environment and help us understand the broader picture. We interpret hormone levels alongside your symptoms, medical history, menopausal stage and other relevant factors rather than using a single laboratory value in isolation.
Are the hormones similar to the hormones my body naturally makes?
Hormone therapy can use hormones that are similar in chemical structure to hormones naturally produced by the body. The appropriate hormone, formulation, route and dose depend on your individual needs and medical history.
How long can I stay on hormone therapy?
There is no single duration that applies to every woman. Continuing therapy is an ongoing clinical decision, with periodic reassessment of symptoms, benefits, risks and changing health circumstances.
What if hormone therapy isn't right for me?
There are other ways to address menopausal symptoms and support health during and after the menopausal transition. The right approach depends on what you are experiencing, your health history and your goals.
Begin with a conversation.

For Men
Hormone Therapy for Men
Testosterone is only one part of the male hormonal system. It interacts with estrogen, DHEA, cortisol, thyroid hormones, insulin, and other metabolic signals—and changes in one part of that system can affect how a man feels, performs, and ages.
For some men, low testosterone is a clear medical problem. For others, the same symptoms may have another cause. The important question is not simply whether testosterone can be prescribed. It is whether testosterone deficiency is actually present, what is contributing to it, and whether treatment is appropriate for that individual.
What's changed
For years, concerns about testosterone therapy focused heavily on cardiovascular and prostate risk. As research has evolved, the conversation has become more specific.
Testosterone therapy is not appropriate simply because testosterone declines with age, and it is not a general treatment for every symptom of aging. At the same time, appropriately evaluated men with genuine testosterone deficiency may experience meaningful improvement in symptoms and function.
The question is no longer simply "Is testosterone safe?"
It is: "Is testosterone deficiency present, why is it present, and would treatment benefit this particular man?"
That distinction matters.
What testosterone does
Testosterone is important throughout a man's life. It contributes to sexual function, muscle development and maintenance, bone health, body composition, energy, and aspects of mood and cognition.
But testosterone does not act alone.
Testosterone is converted in the body into other active hormones, including estradiol and dihydrotestosterone. A substantial portion of circulating testosterone is bound to proteins, particularly sex hormone-binding globulin (SHBG). The amount of testosterone available to tissues therefore cannot always be understood from total testosterone alone.
This is one reason a single testosterone number can be misleading.
The symptoms nobody connects
Low testosterone does not always announce itself with a change in libido.
Some men notice:
- Loss of drive or motivation
- Fatigue that does not resolve with adequate sleep
- Flat or irritable mood
- Brain fog or difficulty concentrating
- Reduced exercise response
- Slower recovery from training
- Loss of muscle or increasing body fat
- Declining strength
- Reduced bone density
- Fewer spontaneous or morning erections
- Erectile dysfunction
- A general sense that something has changed
These symptoms are often attributed to stress, getting older, depression, poor sleep, or simply "life."
Sometimes that explanation is correct.
Sometimes it is not.
The purpose of evaluation is to determine which is which.
Beyond libido
Testosterone is often discussed as though its only meaningful effect is sexual.
It is much broader than that.
Adequate testosterone is important for maintaining muscle and bone and is associated with body composition and metabolic health. Testosterone deficiency can occur alongside obesity, insulin resistance, type 2 diabetes, and sleep disorders, while those same conditions can also contribute to lower testosterone.
This relationship can become a cycle.
Metabolic dysfunction can suppress testosterone. Lower testosterone can make maintaining muscle and healthy body composition more difficult. Sleep disorders and chronic illness can further affect hormonal signaling.
That is why treating the hormone without looking at the environment in which the hormone is functioning may miss part of the problem.
At Metaglow, we look for the contributors as well as the number.
Is testosterone actually low?
A diagnosis of testosterone deficiency should not be made from symptoms alone—and it should not be made from one laboratory result alone.
Testing begins with testosterone, generally measured in the morning when levels are highest. If the result is low or borderline, it is confirmed with repeat testing.
We also look at the factors that determine how much testosterone is actually available to tissues, including:
- Total testosterone
- Free or bioavailable testosterone when appropriate
- SHBG
- Albumin
- LH and FSH when indicated
LH and FSH help determine whether the problem originates primarily in the testes or involves the hypothalamic-pituitary system.
The rest of the evaluation depends on the individual. Medications, obesity, metabolic disease, sleep apnea, illness, nutritional status, testicular conditions, and other hormonal abnormalities can all influence testosterone production.
The goal is not to chase a number.
The goal is to understand the hormonal picture.
Who may benefit—and who may not
Testosterone therapy is intended for men with documented testosterone deficiency in the appropriate clinical setting—not simply for men who want a higher testosterone level.
A man with symptoms and repeatedly low testosterone may be an appropriate candidate for treatment.
A man with normal testosterone may not be.
And a man with low testosterone may first need evaluation and treatment of an underlying contributor rather than immediate hormone replacement.
This is particularly important when obesity, insulin resistance, sleep apnea, medication effects, systemic illness, or another endocrine problem may be affecting testosterone production.
Hormone therapy should fit the diagnosis—not replace the diagnosis.
Fertility changes the conversation
Testosterone therapy can suppress the body's own production of testosterone and can reduce sperm production.
For a man who is trying to conceive, this is not a minor consideration.
Before beginning treatment, fertility goals should be discussed explicitly. Depending on the situation, other approaches may be considered when preserving or restoring sperm production is important.
A treatment that improves testosterone symptoms but compromises a man's reproductive goals is not the right treatment for that man.
Cardiovascular considerations
The cardiovascular conversation around testosterone has changed substantially as evidence has accumulated.
Testosterone should not be prescribed indiscriminately, but current evidence does not support the idea that appropriately selected men with testosterone deficiency should automatically be denied treatment because of cardiovascular concerns.
Risk still has to be considered individually.
Existing cardiovascular disease, uncontrolled risk factors, elevated hematocrit, sleep apnea, medications, metabolic health, and the reason for the testosterone deficiency all matter.
The objective is physiologic treatment with appropriate monitoring—not pushing testosterone to supraphysiologic levels.
What about the prostate?
Testosterone and prostate health require appropriate evaluation, but the relationship is more nuanced than the old idea that testosterone simply "feeds" prostate cancer.
Before treatment, prostate history and risk are reviewed, with PSA testing and other evaluation as appropriate for the individual.
Men with known or suspected prostate cancer require a different approach.
Once treatment begins, prostate-related monitoring continues according to age, risk, history, symptoms, and clinical guidelines.
How evaluation works at Metaglow
A testosterone prescription should be the end of an evaluation, not the beginning.
At Metaglow, the process includes:
- Understanding the symptoms and when they began.
- Reviewing medical history, medications, sleep, metabolic health, exercise, nutrition, and other potential contributors.
- Measuring testosterone appropriately and confirming deficiency when indicated.
- Looking beyond total testosterone when necessary, including SHBG and free or bioavailable testosterone.
- Using LH and FSH and other testing when needed to understand the cause.
- Reviewing fertility goals before treatment.
- Assessing factors that may make testosterone therapy inappropriate or require additional evaluation.
- Discussing formulation, route, dosing, expected benefits, and potential risks.
- Reassessing symptoms and laboratory markers rather than assuming that treatment should continue indefinitely.
Treatment is individualized.
The goal is not to create an artificially high testosterone level. It is to restore an appropriate physiologic range when deficiency is genuinely present and treatment is appropriate.
Monitoring matters
Testosterone therapy changes physiology, so it requires follow-up.
Monitoring may include testosterone levels, CBC and hematocrit, PSA when appropriate, symptoms, blood pressure, metabolic markers, and other measures based on the individual's health and treatment.
Hematocrit deserves particular attention. Testosterone can increase red blood cell production, and excessive elevation may increase risk. If hematocrit rises substantially, the answer is not simply to repeatedly remove blood while continuing the same dose. The testosterone dose and treatment strategy need to be reassessed.
The objective is effective treatment at the lowest appropriate physiologic exposure—not more testosterone for its own sake.
What if testosterone isn't the answer?
Not every man with fatigue, low motivation, erectile dysfunction, poor recovery, or changing body composition has low testosterone.
Sleep apnea, insulin resistance, obesity, thyroid dysfunction, medication effects, chronic illness, nutritional deficiencies, excessive stress, depression, and other hormonal or metabolic problems can produce overlapping symptoms.
Sometimes the most important intervention is not testosterone.
It may be treating the condition suppressing testosterone production. It may be improving sleep. It may be addressing metabolic dysfunction. It may be evaluating another hormone.
And sometimes the appropriate conclusion is that testosterone therapy is not indicated.
That is why we evaluate the whole picture before deciding on treatment.
Frequently Asked Questions
Do I need low libido to consider testosterone therapy?
No.
Low libido and erectile dysfunction are important symptoms of testosterone deficiency, but they are not the only ones. Fatigue, reduced muscle mass, poor recovery, changes in body composition, mood changes, and loss of spontaneous erections can also occur.
Symptoms alone, however, do not establish testosterone deficiency. They need to be interpreted together with appropriately obtained laboratory testing and the rest of the clinical picture.
My testosterone was "normal." Does that settle it?
Not necessarily—but neither does one borderline result prove deficiency.
Total testosterone does not tell the entire story. SHBG affects how much testosterone is available to tissues, and free or bioavailable testosterone may provide additional information in selected patients.
Timing matters, and an unexpectedly low result generally needs confirmation.
The important question is not simply whether one number falls inside a laboratory reference range. It is whether the laboratory findings, symptoms, clinical history, and hormonal context fit together.
Is testosterone safe for the heart?
Cardiovascular risk should be evaluated individually rather than reduced to a simple yes-or-no rule.
Current evidence has not shown that appropriately prescribed testosterone therapy inevitably causes cardiovascular events in men with genuine testosterone deficiency. At the same time, testosterone is not appropriate for every man, and cardiovascular disease and risk factors should be considered before and during treatment.
Will testosterone affect fertility?
Yes.
Exogenous testosterone can suppress sperm production. If fertility is an immediate or future goal, that discussion belongs before treatment begins—not after.
Does testosterone increase prostate cancer risk?
Testosterone therapy requires prostate evaluation and ongoing monitoring, but the relationship between testosterone and prostate cancer is more complex than the traditional assumption that higher testosterone necessarily causes prostate cancer.
Men with known or suspected prostate cancer require appropriate specialist evaluation before testosterone therapy is considered.
How long do I need to take testosterone?
There is no universal duration.
If a man has a persistent cause of testosterone deficiency and experiences meaningful benefit from treatment, therapy may be long term. If an underlying reversible contributor can be corrected, testosterone production may improve and treatment may be reconsidered.
The decision is revisited over time based on symptoms, laboratory results, health status, and treatment goals.
What if my testosterone is low because of another problem?
That is an important question.
Low testosterone can be a consequence of another medical or metabolic problem. Obesity, insulin resistance, sleep apnea, certain medications, chronic illness, and disorders of the hypothalamic-pituitary-testis axis can all affect testosterone.
In those situations, identifying and treating the underlying contributor may be an essential part of restoring hormonal function.
At Metaglow, we do not view testosterone as an isolated number or hormone. We look at the system around it.
Hormone therapy should be individualized
Testosterone can be an important treatment when a man is genuinely deficient and the treatment is appropriate.
But more is not better.
The goal is not optimization for its own sake. It is to identify deficiency, understand why it is occurring, determine whether treatment is appropriate, and monitor the response carefully over time.
That is the difference between simply prescribing testosterone and practicing hormone medicine.
Last medically reviewed by Emma Kruger, M.D. · September 20, 2026